Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data.
暂无分享,去创建一个
[1] A. Lenzi,et al. Testosterone and metabolic syndrome: a meta-analysis study. , 2011, The journal of sexual medicine.
[2] A. Lenzi,et al. Type 2 diabetes mellitus and testosterone: a meta-analysis study. , 2011, International journal of andrology.
[3] E. Giltay,et al. Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double‐blinded placebo‐controlled Moscow study , 2010, Clinical endocrinology.
[4] P. Morris,et al. Low serum testosterone and increased mortality in men with coronary heart disease , 2010, Heart.
[5] A. Lenzi,et al. Effects of Testosterone Undecanoate on Cardiovascular Risk Factors and Atherosclerosis in Middle-Aged Men with Late-Onset Hypogonadism and Metabolic Syndrome : Results from a 24-month , Randomized , Double-Blind , Placebo-Controlled Studyjsm , 2010 .
[6] T. Jones. Testosterone deficiency: a risk factor for cardiovascular disease? , 2010, Trends in Endocrinology & Metabolism.
[7] A. Jette,et al. Adverse events associated with testosterone administration. , 2010, The New England journal of medicine.
[8] M. Kaushik,et al. Cardiovascular disease and androgens: a review. , 2010, International journal of cardiology.
[9] M. Volterrani,et al. Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease. , 2010, International journal of cardiology.
[10] Amy T. Wang,et al. Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. , 2010, The Journal of clinical endocrinology and metabolism.
[11] V. Víctor,et al. Testosterone levels in males with type 2 diabetes and their relationship with cardiovascular risk factors and cardiovascular disease. , 2010, The journal of sexual medicine.
[12] F. Iellamo,et al. Testosterone Deficiency and Exercise Intolerance in Heart Failure: Treatment Implications , 2010, Current heart failure reports.
[13] S. Roberts,et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. , 2010, The Journal of clinical endocrinology and metabolism.
[14] F. Saad,et al. The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process. , 2009, Atherosclerosis.
[15] Anke Richter,et al. Recommendations for increasing the use of HIV/AIDS resource allocation models , 2009, BMC public health.
[16] M. Bunck,et al. Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. , 2009, Journal of andrology.
[17] J. Hansen,et al. Impact of long-term testosterone treatment on plasma levels of free TFPI and TF-induced thrombin generation ex vivo in elderly men with low testosterone levels , 2009, Thrombosis and Haemostasis.
[18] F. Iellamo,et al. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. , 2009, Journal of the American College of Cardiology.
[19] K. Channer,et al. Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men. , 2009, European journal of endocrinology.
[20] G. Rosano,et al. Gender differences in the cardiovascular effect of sex hormones , 2009, Nature Reviews Cardiology.
[21] S. Azen,et al. Testosterone and growth hormone improve body composition and muscle performance in older men. , 2009, The Journal of clinical endocrinology and metabolism.
[22] Wei Zhang,et al. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis , 2009, BMC public health.
[23] R. Shah,et al. A population-based study of hemoglobin, race, and mortality in elderly persons. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.
[24] D. Pennell,et al. Effects of Oral Testosterone Treatment on Myocardial Perfusion and Vascular Function in Men With Low Plasma Testosterone and Coronary Heart Disease , 2008, The American journal of cardiology.
[25] R. Califf,et al. Prediction of One-Year Survival in High-Risk Patients with Acute Coronary Syndromes: Results from the SYNERGY Trial , 2008, Journal of General Internal Medicine.
[26] D. Grobbee,et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. , 2008, JAMA.
[27] K. Channer,et al. The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. , 2007, European journal of endocrinology.
[28] G. Rosano,et al. Low testosterone levels are associated with coronary artery disease in male patients with angina , 2007, International Journal of Impotence Research.
[29] K. Channer,et al. The effect of testosterone on insulin sensitivity in men with heart failure , 2007, European journal of heart failure.
[30] Hang Lee,et al. Effects of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men. , 2006, European journal of endocrinology.
[31] P. Ponikowski,et al. Anabolic Deficiency in Men With Chronic Heart Failure: Prevalence and Detrimental Impact on Survival , 2006, Circulation.
[32] W. Weidemann,et al. Cardiovascular effects of androgens. , 2006, Cardiovascular drug reviews.
[33] K. Channer,et al. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. , 2006, European journal of endocrinology.
[34] E. Ding,et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. , 2006, JAMA.
[35] F. Martin,et al. The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. , 2006, The Journal of clinical endocrinology and metabolism.
[36] Martin L. Lee,et al. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.
[37] J. Kaufman,et al. The decline of androgen levels in elderly men and its clinical and therapeutic implications. , 2005, Endocrine reviews.
[38] A. Lenzi,et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle‐aged men: a meta‐analysis , 2005, Clinical endocrinology.
[39] R. Jones,et al. Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina. , 2005, European journal of endocrinology.
[40] J. Nettleship,et al. Physiologic Testosterone Therapy has no Effect on Serum Levels of Tumour Necrosis Factor-α in Men with Chronic Heart Failure , 2005, Endocrine research.
[41] P. Delmas,et al. Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: the MINOS study. , 2004, The American journal of clinical nutrition.
[42] R. Jones,et al. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life , 2004, Heart.
[43] P. Savage,et al. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. , 2004, Diabetes.
[44] K. Channer,et al. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. , 2004, The Journal of clinical endocrinology and metabolism.
[45] R. Jones,et al. Testosterone treatment for men with chronic heart failure , 2004, Heart.
[46] P. Morris,et al. Effect of testosterone therapy on QT dispersion in men with heart failure. , 2003, The American journal of cardiology.
[47] A. Eckardstein,et al. Testosterone and atherosclerosis. , 2003, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[48] H. Tunstall-Pedoe,et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.
[49] A. Kenny,et al. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.
[50] R. Wolfe,et al. Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. , 2002, American journal of physiology. Endocrinology and metabolism.
[51] R. Steeds,et al. Chronic Stable Angina : A Randomized , Double-Blind , Placebo-Controlled Study Low-Dose Transdermal Testosterone Therapy Improves Angina Threshold in Men With , 2000 .
[52] R. Steeds,et al. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. , 2000, European heart journal.
[53] C. Hayward,et al. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. , 1999, Circulation.
[54] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[55] H. Burger,et al. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men. , 2008, The Journal of clinical endocrinology and metabolism.
[56] V. Montori,et al. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. , 2007, Mayo Clinic proceedings.
[57] E. V. van Beek,et al. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. , 2006, European heart journal.
[58] J. Nettleship,et al. Testosterone and Atherosclerosis in Aging Men , 2005, American journal of cardiovascular drugs : drugs, devices, and other interventions.